Early Warning Report of Michael Wekerle This press release

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
415
Early Warning Report of Michael Wekerle

This press release is issued pursuant to National Instrument 62-104 – Take-Over Bids and Issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with the filing of an early warning report dated the date hereof.   

TORONTO, May 23, 2018 (GLOBE NEWSWIRE) -- Michael Wekerle (“ Wekerle ”) filed an early warning report today in connection with the acquisition by Difference Capital Financial Inc. (“ DCF ”), which is an associate of Wekerle, of 250,000 common shares (the “ Shares ”) in the capital of Mogo Finance Technology Inc. (“ Mogo ”) through the facilities of the Toronto Stock Exchange at a price of $3.20 per share (the “ Transaction ”).  Wekerle relied upon the private agreement exemption contained in Section 4.2 of National Instrument 62-104 – Take-Over Bids and Issuer Bids to make this purchase.

Prior to the acquisition of the Shares, Wekerle held an aggregate of 2,520,754 Shares directly and DCF held 1,024,751 Shares. Wekerle also held an aggregate $2,000,000 principal amount of 10% senior secured convertible debentures of Mogo (the “ Debentures ”) and DCF held $3,641,000 principal amount of Debentures. Each Debenture is convertible into Shares at a price per Share equal to $5.00. Assuming the conversion of all of the Debentures held by Wekerle and DCF, the two parties collectively had control or direction of an aggregate of 4,673,705 Shares, representing 19.99% of the issued and outstanding Shares. Following the acquisition of the Shares and assuming the conversion of all of the Debentures held by Wekerle and DCF, the two parties collectively have control or direction of an aggregate of 4,923,705 Shares, representing 21.06% of the issued and outstanding Shares. 

The Shares were purchased by DCF for investment purposes. Wekerle expects to evaluate on an ongoing basis Mogo’s financial condition, results of operations, business and prospects, the market price of the Shares, conditions in securities markets generally and in the market for shares of companies like Mogo, general economic and industry conditions and other factors that Wekerle deems relevant to his investment decisions. Based on such evaluations, Wekerle may at any time or from time to time determine to acquire additional Shares, or securities convertible into or exchangeable for Shares or derivatives relating to Shares, or to dispose of Shares or securities convertible into or exchangeable for Shares or derivatives relating to Shares that Wekerle owns or may hereafter acquire, through open market or privately negotiated transactions or otherwise, at such prices and on such terms as he deems advisable. Wekerle intends to monitor his investment in Shares. Wekerle and his representatives and advisers may communicate with other shareholders, industry participants and other interested parties concerning Mogo. In addition, based on Wekerle’s continuing evaluation of the foregoing factors, Wekerle reserves the right to change his plans and intentions at any time or from time to time, as he deems appropriate.

The above-referenced early warning report relating to this press release has been filed on System for Electronic Document Analysis and Review (SEDAR) at www.sedar.com under Mogo’s issuer profile. For further information or to obtain a copy of the early warning report please contact Kelly Pullen at 647-985-5798.

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Eli Lilly's Pirtobrutinib Shows Promising Results in CLL Trials

Updated Category News Views 158

Pirtobrutinib's Efficacy in Chronic Lymphocytic Leukemia Studies Eli Lilly and Company (NYSE: LLY) made notable advancements in chronic lymphocytic leukemia (CLL) research with their drug, pirtobrutinib. The recent study, known as BRUIN CLL-321, demonstrated that pirtobrutinib significantly reduced the risk of disease progression or death by 46% compared to previous...

Continue Reading
Exploring Axon Enterprise's Options Trading Dynamics

Updated Category News Views 173

Investors' Insights on Axon Enterprise In the ever-evolving world of stock market investments, insights from institutional and wealthy individual investors can carry significant weight. Recently, there has been a noticeable bullish stance on Axon Enterprise (NASDAQ: AXON), raising curiosity among retail traders about potential future movements. Unusual Options Activity...

Continue Reading
Aventis Energy Releases Technical Report on Corvo Project

Updated Category News Views 143

Aventis Energy Files NI 43-101 Technical Report on Corvo Project Aventis Energy Inc. (“Aventis” or the “Company”) (CNSX: AVE | Frankfurt: C0O0 | Other OTC: VBAMF) is excited to announce that its partner, Standard Uranium Ltd., has filed a technical report detailing findings and exploration data from the Corvo Project. This report, titled "Technical Report on the...

Continue Reading
Drucker + Falk Celebrates Community Commitment Through Cleanup Events

Updated Category News Views 108

Drucker + Falk's Dedication to Community Engagement Drucker + Falk, a prominent name in multifamily property management, has made remarkable strides in community involvement through its annual clean-up initiatives. This year, they marked the third consecutive clean-up campaign aimed at enhancing local environments, aligning their efforts with the mission of Keep America...

Continue Reading
Exploring the Future of Mental Health: The Wholeness Center

Updated Category News Views 96

Revolutionizing Mental Health with Integrative Approaches The Wholeness Center has gained state approval to offer legal psilocybin-assisted therapy, marking a significant milestone as the sole licensed healing center in Northern Colorado. This innovative facility combines the realms of psychedelic therapy with integrative psychiatry, aiming to provide comprehensive mental...

Continue Reading